Sep 9, 2026 08:02AM
Sep 9, 2026 08:00AM
Aug 25, 2026 08:46AM
Aug 25, 2026 08:46AM
Jul 23, 2026 08:00AM
Jul 23, 2026 08:00AM
Jun 25, 2026 08:00AM Incannex gets U.S. patent for sleep apnea drug IHL-42X through 2040
Jun 25, 2026 08:00AM
May 14, 2026 10:35AM
May 14, 2026 10:35AM
Apr 22, 2026 08:04AM
Apr 22, 2026 08:00AM
Mar 18, 2026 08:02AM
Mar 18, 2026 08:00AM Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development
Mar 12, 2026 08:00AM
Mar 12, 2026 08:00AM
Jan 29, 2026 08:00AM
Jan 29, 2026 08:00AM
Jan 14, 2026 08:00AM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)
Nov 20, 2025 09:34AM
Oct 30, 2025 08:00AM
Aug 26, 2025 08:00AM
Aug 26, 2025 08:00AM
Aug 8, 2025 08:00AM
Aug 8, 2025 08:00AM
Jul 30, 2025 08:00AM Incannex reports positive Phase 2 results for sleep apnea drug candidate
Jul 30, 2025 08:00AM
Jun 12, 2025 07:30AM
May 29, 2025 07:30AM
May 29, 2025 07:30AM
May 28, 2025 07:00AM
May 28, 2025 07:00AM
May 15, 2025 08:00AM Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates
May 14, 2025 08:00AM
Apr 3, 2025 07:30AM
Feb 14, 2025 07:30AM
Jan 23, 2025 07:30AM
Jan 23, 2025 07:30AM
Dec 2, 2024 04:48PM
Nov 14, 2024 04:05PM Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates
Oct 24, 2024 07:30AM
Oct 24, 2024 07:30AM
Oct 2, 2024 04:50PM
Sep 30, 2024 04:01PM
Sep 9, 2024 08:00AM
Aug 5, 2024 07:30AM
Jul 30, 2024 07:30AM Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X
May 30, 2024 07:30AM

330,741 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All